• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Neurochemical study far psyyootropic actions of general anesthetics

Research Project

Project/Area Number 18591712
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Anesthesiology/Resuscitation studies
Research InstitutionFukushima Medical University

Principal Investigator

MURAKAWA Masahiro  Fukushima Medical University, Department of Anesthsiology, Professor (90182112)

Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥3,710,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥510,000)
Fiscal Year 2007: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2006: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywordsgeneral anesthetics / Nitrous oxide / Cannabinoid receetor / Anandamide / Rimonabant / tail flick test / acute tolerance / 鎮痛作用
Research Abstract

To clarify the neurochemical basis for psycotropic actions of general anesthetics, the relationship between the endocannabinoid system and central nervous system actions of nitrous oxide was studied.
Male Wistar. rats were received cannabinoid 1 receptor antagonist, rimonabant, intraperitoneally, intraventricularly, intrathecally respectively Thirty minutes after rimonabant injection, 75% nitrous oxide was given to animals for: 180 min. The tail flick test was performed every 30 min, from 0 to 210 min.
In control group, the percent of maximal possible effect (%MPE) of the tail flick test increased with nitrous oxide inhalation. The peak effects occurred after 30 min of nitrous oxide administration, and then %MPE gradually decreased to the baseline level: the development of acute tolerance to the analgesic action of nitrous oxide. However; in the group administered rimonabant 5 mg/kg intraperitoneally and 10 μg intraventricularly, %MPE did not decrease from the peak level In contrast, %MP … More E in the-rats injected rimonabant 10 μ g intrathecally did not increase with nitrous oxide inhalation.
Nitrous oxide is widely used inhaled anesthetics in humans for a long time and induces analgesia, euphoria and drug abuse. In addition, the development acute tolerance to the analgesic effect is known in various animals. The endocannabinoid, anandamide, acts as an agonist on cannabinoid 1 receptor activates intracerebral dopaminergic reward system. In the results of this study, the central nervous system actions of nitrous oxide were not blocked by intraperitneal and intraventricular rimonabant However intrathecal rimonabant antagonized the analgesic action of nitrous oxide. The endocannabinoid might interact with nitrous oxide in spinal level; anandamide participated in the development of acute tolerance to the analgesic action of nitrous oxide. Therefore, the results of this study provide the neurochemical basis for the fact that interaction between anandamide and nitrous oxide in the cerebral cortex might differ from in the spinal cord. Less

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (2 results)

All 2008

All Presentation (2 results)

  • [Presentation] 亜酸化窒素の鎮痛作用に及ぼす脳内アナンドマイドの影響2008

    • Author(s)
      箱崎 貴大, 他
    • Organizer
      第12回日本神経麻酔・集中治療研究会
    • Place of Presentation
      新潟市
    • Year and Date
      2008-04-12
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Annual Research Report 2007 Final Research Report Summary
  • [Presentation] The effects of anandamide in the central nervous,system on nitrous.oxide analgesia in rats.2008

    • Author(s)
      Hakozaki, T., Nemoto, C., Ssnbe, N., Ohara, S., Tiosu, T., MuriikawEi, M
    • Organizer
      Japanae Society for Pharmaco-anesthesiology, 12th Scientific Congress
    • Place of Presentation
      Niigata City
    • Year and Date
      2008-04-12
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi